Second Sight Med

EYES NASDAQ
0.8700
+0.0504
+6.15%
After Hours: 0.8433 -0.0267 -3.07% 16:31 05/22 EDT
Open
0.8100
Prev Close
0.8196
High
0.8909
Low
0.8100
Volume
181.78K
Avg Vol (3M)
344.51K
52 Week High
2.250
52 Week Low
0.6351
% Turnover
0.15%
Market Cap
108.05M
1D
5D
1M
3M
1Y
5Y

Comments

No Data

Related

Webull offers Second Sight Med EYES stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Second Sight Medical Products, Inc. is engaged in developing, manufacturing and marketing prosthetic devices that restore vision to blind individuals. The Company intends to develop Orion Visual Cortical Prosthesis which provides useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease or forms of cancer and trauma. Its product, The Argus II Retinal Prosthesis System (The Argus II) provides electrical stimulation of the retina to induce visual perception in blind individuals and helps in treating outer retinal degenerations, such as retinitis pigmentosa (RP). The Argus II System provides an artificial form of vision that differs from the vision of people with normal sight. The Company's Argus II System employs electrical stimulation to bypass degenerated photoreceptor cells and to stimulate remaining viable retinal cells thereby inducing visual perception in blind individuals.
MORE >

Recently

Name
Price
%Change